Mycobacterial Infections Flashcards

1
Q

Goals of TB Treatment is to NEVER

A

Treat w/ single drug or add single drug to failing regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Directly Observed Therapy

A

Preferred management strategy for ALL patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For drug-resistant TB use

A

The daily regimen & DOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anti -TB 1st line Drugs

A
Ethambutol
Isoniazid
Pyrazinamide
Rifabutin
Rifampin
Rifapentine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anti - TB 2nd line Drugs

A
Bedaquiline 
Capreomycin
Cycloserine
Ethionamide
p-Aminosalicyclic acid
Streptomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 regimens recommended for TB (drug susceptible) treatment are

A

Initial phase: standard 4 drugs INH, PZA, EMB, RIF for 2 months (1 excludes PZA)
Continuation phase: Additional 4 months or 7 months for some

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Isoniazid: MOA

A

1) Most potent - don’t use as single agent
2) Pyridoxine synthetic analog
3) Bacteriostatic for stationary phase; Bactericidal for dividing phase
4) Intracellular bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isoniazid: PK

A

Oral - readily absorbed
Food disrupts absorption (Carbs, aluminum antacids)
In infected tissues
Glomerular filtration as metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Isoniazid: Pt metabolism

A

1) N-acetylation & hydrolysis = inactive products
2) Slow acetylators excrete more of the parent compound = long half life
3) Rapid acetylators = short half life
4) Poor renal function = drug accumulation
5) Chronic liver disease decreases metabolism (reduce dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Isoniazid: drug interactions

A

Increases blood levels of phenytoin (dilatin) & disulfiram (antabuse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pyrazinamide: MOA

A

1) Pyrazine analog of Nicotinamide
2) Hydrolyzed becomes pyrazinoic acid
3) Bactericidal for dividing phase - unknown mechanism
4) Bacteria in lysosomes & macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pyrazinamide: PK

A

1) Oral >90% bioavailability
2) GI absorption
3) Found in lung epithelial lining fluid
4) Body distribution (CSF penetration)
5) Renal issues = poor metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Issues of Pyrazinamide & Ethambutol

A

Gouty attacks

Urate retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ethambutol

A

1) TB, disseminated MAC, M. kansasii infection
2) Bacteriostatic
3) Arabinosyl transferase inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arabinosyl transferase inhibition =

A

Disrupts arabinogalactan cell wall formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ethambutol: PK

A

1) Oral ~ 80% BA
2) Body distribution (CSF penetration)
3) Glomerular filtration & Tubular secretion
4) Dose 3x a week in ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ethambutol: Issues

A

Optic neuritis

  • visual acuity decreased
  • hard to discriminate red & green
  • reversible
18
Q

Rifamycins

A

1) Similar macrocyclic antibiotics

2)

19
Q

Rifapentine & Rifabutin are

A

Rifampin derivatives

20
Q

Rifampin inhibits

A

Gram positive growth & some gram negative

21
Q

Rifampin is bactericidal against

A

M. leprae

22
Q

Rifampin: MOA

A

1) Never as a single agent

2) RNA polymerase inhibitor

23
Q

Rifampin: PK

A

1) Absorption (decreased with food)
2) Body distribution (CSF penetration)
3) Enterohepatic cycling
4) Bile elimination into feces or urine
4) Orange color secretions

24
Q

Rifampin: drug interactions

A

Induces CYPs of other drugs: 1A2, 3A4, 2C9, 2C19 = therapeutic failure of these agents

25
Q

Rifabutin

A

1) Food has no effect
2) Less potent inducer of P450
3) Used for HIV on protease inhibitors or nonnucleoside reverse transcriptase inhibitors
4) Uveitis, skin hyperpigmentation, neutropenia

26
Q

Rifapentine

A

1) High fat meal increases AUC by 50%
2) Intermediate CYP inducing effects
3) Toxicity similar to rifampin

27
Q

Bedaquiline

A

1) Adults >18 w/ MDR TB
2) 4-5 mo half life
3) DOT
4) Food to maximize absorption
5) QT prolongation, hepatotoxicity
6) Not with rifamycins or other CYP3A4 inducers

28
Q

Drug Susceptibility Test

A

Culture is standard.

Xpert MTB/RIF assay: NAA test, 2hrs

29
Q

INH monoresistant TB

A

1) Use other 3 1st line drugs for 6 months or add FQ fot the 3 drug regimen (6 mo)

30
Q

MDR TB or RIF resistant TB

A

1) Induction: 5 drugs to which isolate is susceptible including FQ and injectable aminoglycoside
2) Continuation: treat with 4 of the drugs (remove injectable)

31
Q

Shorter MDR TB regimen

A

7 drugs given for 9-12 months

32
Q

Latent TB - INH 9 months

A

Daily:

1) HIV
2) Children 2-11 yrs old
3) Pregnant women (w/ pyridoxine/vitamin B6 supp)

2x weekly
1) pregnant women (w/ pyridoxine/vitamin B6 supp)

33
Q

Latent TB - INH 6 months

A

Daily NOT for:

1) HIV
2) Fibrotic lesions
3) Children

34
Q

Latent TB - INH +Rifapentine 3 months DOT

A

Weekly, NOT for:

1) HIV/AIDs
2) Resistant MTb
3) Pregnant
4) Children < 2 yo

35
Q

Rifamycin 4 months

A

Daily, NOT for:

1) Pt. on drugs that interact w/ rifamycins
2) Pt. with contact lenses
3) Pregnant or expect to become pregnant

36
Q

Treatment Regimens: Pregnancy

A

1) Initial: INH, RIF, EMB
2) Streptomycin contraindicated
3) PZA can be used
4) 9 months therapy when PZA not used
5) Can breastfeed
6) Vitamin B6 recommended with INH
7) MDR TB? Consult expert

37
Q

Treatment Regimens: Children/Infants

A

1) same as adults except EMB
2) Treat as soon as diagnosis is suspected
3) Disseminated TB or TB meningitis in children, treat for 9 to 12 mo

38
Q

Treatment Regimens: HIV/AIDS

A

1) Same principles as HIV negative patients
2) 6 mo daily regimen
- 2 months of INH, Rifamycin, PZA, EMB
- 4 months of INH, Rifamycin
3) treat empirically, DOT

39
Q

Treatment Regimens: Latent TB HIV/AIDS

A

INH daily for 9 months

40
Q

HIV/AIDS Drug interactions

A

Rifampin does drug interactions with PIs & NNRTIs

Use Rifabutin

41
Q

Treatment of Disseminated MAC

A

Clarithromycin or Azithromycin and ethambutol w/ or w/o rifabutin

42
Q

Prophylaxis of disseminated MAC of AIDS w/ CD4 <50

A

Azithromycin or Clarithromycin